The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 373.50
Bid: 371.50
Ask: 372.50
Change: 6.00 (1.63%)
Spread: 1.00 (0.269%)
Open: 367.00
High: 374.50
Low: 366.00
Prev. Close: 367.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Dec 2018 11:20

RNS Number : 8413K
Breedon Group PLC
18 December 2018
 

 

 

18 December 2018

 

 

BREEDON GROUP PLC ("bREEDON" OR "tHE GROUP")

 

RETIREMENT OF NON-EXECUTIVE DIRECTOR

 

 

David Warr, who has been a non-executive director of Breedon since the company's shares were admitted to AIM in 2008, will retire from the Board on 31 December 2018.

 

Commenting on his retirement Peter Tom CBE, Executive Chairman, said: "David has served the Group with great dedication and professionalism over the last 10 years and on behalf of the Board I would like to thank him for his considerable contribution and wish him well for the future."

 

David has served as Chairman of the Audit Committee throughout his time on the Board and will be succeeded in this role by Susie Farnon, Breedon's senior independent non-executive director.

 

Following the appointment of Peter Cornell as a non-executive director in October this year, the Group is in the final stages of appointing a second additional independent non-executive director and expects to make a formal announcement early in the new year.

 

- ends -

 

 

 

 

Enquiries:

Breedon Group plc 01332 694010

Peter Tom Executive Chairman

Pat Ward, Group Chief Executive

Stephen Jacobs, Head of Communications 07831 764592

 

Cenkos Securities plc (Nomad and joint broker) 020 7397 8900

Max Hartley

 

Numis Securities (joint broker) 020 7260 1000

Ben Stoop / Heraclis Economides

 

 

 

Notes to editors

Breedon Group plc is a leading construction materials group in the UK and Ireland. It currently operates two cement plants, around 80 quarries, 40 asphalt plants, around 170 ready-mixed concrete and mortar plants, nine concrete and clay products plants, four contract surfacing businesses, six import/export terminals and two slate production facilities. The Group employs nearly 3,000 people and has nearly 900 million tonnes of mineral reserves and resources. The Group's strategy is to continue growing organically and through the acquisition of businesses in the heavyside construction materials market.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFVLFFVLFFFBQ
Date   Source Headline
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022
18th Jul 20224:37 pmRNSStandard form for notification of major holdings
7th Jul 20223:49 pmRNSBlocklisting Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.